Please review the following CME information before selecting the Begin the Program button found at the bottom of this page.
PROGRAM DESCRIPTION
Cosmetic dermatology is a relatively new branch of the specialty that is experiencing dynamic growth. Recent advances in treatment options to improve the appearance, particularly of the aging face, have made this area of dermatology a challenging endeavor for clinicians but, at the same time, an intervention with typically highly satisfying results for both patients and clinicians who are trained and skilled at using these techniques. In addition to the cosmetic benefits for patients who seek rejuvenation due to age-related changes, facial fillers and volumizers, in particular, are useful for mitigating the deleterious effects of modern treatment regimens for patients with HIV/AIDS.
Successful and safe placement of these products—including botulinum toxin-A
injections, as well as injectable skin fillers such as hyaluronic acid, poly-
L-lactic acid, and calcium hydroxylapatite—demands that dermatologists,
plastic surgeons, and other health care practitioners develop a thorough understanding
of the underlying processes of facial changes. In addition, it is crucial that
health care professionals who wish to offer these services in their practices
undergo the appropriate training. Finally, clinicians must be thoroughly familiar
with the advantages and drawbacks of each of the available products in order
to choose the
best one—or combination—to accommodate individual patients’ needs.
To meet these needs, this webcast featuring injection techniques workshop will present a comprehensive review of the new dermal fillers and volumizers and their appropriate uses in the context of Non-Surgical Total Facial Rejuvenation (NSTFR). The program will cover facial aging, facial treatment zones, regional facial contouring, an overview of filling agents, and the role of dermal augmentation. Particular injection techniques will be demonstrated to provide background for physicians who wish to pursue hands-on training.
Intended Audience
This activity has been developed for dermatologists, plastic surgeons, fellows and residents in plastic surgery and dermatology.
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants should be able to:
- Explain the underlying soft and hard tissue (eg, fat, dermis, bone cartilage, and dentition) changes that occur as a result of intrinsic and extrinsic aging factors that affect the face, and the physical manifestations of those changes;
- List and describe the state-of-the-art modalities currently available for rejuvenation and body sculpting to improve the appearance of biometric volume loss in patients regardless of etiology;
- Discuss the indications and techniques for injecting cosmetic botulinum toxin-A, and fillers and volumizers including hyaluronic acid, poly-L-lactic acid, and calcium hydroxylapatite; and
- Define and explain the category of products referred to as “cosmeceuticals.”
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of Continuing Medical Education (EOCME) and Skin Disease Education Foundation (SDEF). The EOCME is accredited by the ACCME to provide continuing medical education (CME) for physicians.
CME Credit Statement
The EOCME designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
FACULTY DISCLOSURES
As a sponsor accredited by the ACCME, it is the policy of the EOCME to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty of this educational activity discloses the following.
Dr Hamilton is a speaker for
Bioform and Dermik. She is also a consultant for, and has received
clinical funding for grant and research support from Dermik. Dr
Werschler is a consultant, advisory board member, investigator, and speaker for
3M, Allergan, Astellas, Bioform, Clarisonic, DermAvance, Dermik, Galderma,
Genentech, Inamed, Johnson & Johnson, Medicis, Myoscience, Pfizer,
Revance, and Steifel. He will discuss the use of botulinum toxin type
A, cross-linked hyaluronic acid, hydroxylapatite microspheres, and
poly-L-lactic acid for cosmetic use.
resolution of conflict of Interest
The EOCME has implemented a process to resolve conflict of interest for each CME activity. In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, the EOCME has resolved the conflict by external content review.
Unapproved/Off-Label Use Disclosure
The EOCME requires CME faculty to disclose to the participants:
- When products or procedures being discussed are off-label, unlabeled, experimental, and or investigational (not US Food and Drug Administration [FDA] approved); and
- Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research; interim analyses; and/or unsupported opinion.
Faculty may discuss information about pharmaceutical agents that are outside of FDA-approved labeling. This information is intended solely for CME and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
FINANCIAL SUPPORT
This CME activity is supported by an educational grant from
.
Special Needs
We encourage participation by all individuals. If you have any special needs, please contact mededinfo@elsevier.com for assistance.
Hardware and Software Specifications Needed to View
This course requires use of a modern web browser such as Microsoft Internet Explorer, Mozilla Firefox, Apple Safari, Netscape, or Opera. Additionally, to view the presentations requires Flash reader version 6 or later (free download here) and Acrobat Reader Version 5 or later (free download here).


